Authors:
Viallard, JF
Taupin, JL
Ranchin, V
Leng, B
Pellegrin, JL
Moreau, JF
Citation: Jf. Viallard et al., Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis, J RHEUMATOL, 28(1), 2001, pp. 75-80
Authors:
Pellegrin, I
Garrigue, I
Caumont, A
Pellegrin, JL
Merel, P
Schrive, MH
Bonot, P
Fleury, H
Citation: I. Pellegrin et al., Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to astavudine-containing regimen, AIDS, 15(8), 2001, pp. 1071-1073
Authors:
Pellegrin, I
Breilh, D
Birac, V
Deneyrolles, M
Mercie, P
Trylesinski, A
Neau, D
Saux, MC
Fleury, HJA
Pellegrin, JL
Citation: I. Pellegrin et al., Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens, THER DRUG M, 23(4), 2001, pp. 332-340
Authors:
Niobe, SN
Bebear, CM
Clerc, M
Pellegrin, JL
Bebear, C
Maugein, J
Citation: Sn. Niobe et al., Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency virus-infected patient, J CLIN MICR, 39(5), 2001, pp. 2030-2032
Authors:
Viallard, JF
Bloch-Michel, C
Neau-Cransac, M
Taupin, JL
Garrigue, S
Miossec, V
Mercie, P
Pellegrin, JL
Moreau, JF
Citation: Jf. Viallard et al., HLA-DR expression on lymphocyte subsets as a marker of disease activity inpatients with systemic lupus erythematosus, CLIN EXP IM, 125(3), 2001, pp. 485-491
Authors:
Pellegrin, I
Segondy, M
Garrigue, I
Izopet, J
Montes, B
Pellegrin, JL
Reynes, J
Massip, P
Puel, J
Fleury, H
Citation: I. Pellegrin et al., Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy, J ACQ IMM D, 25(5), 2000, pp. 465-466
Authors:
Mercie, P
Viallard, JF
Faure, I
Trimoulet, P
Vital, A
Lifermann, F
Leng, B
Pellegrin, JL
Citation: P. Mercie et al., Hepatitis C virus infection with and without cryoglobulinemia as a case ofChurg-Strauss syndrome, J RHEUMATOL, 27(3), 2000, pp. 814-817
Authors:
Blanco, P
Viallard, JF
Rivel, J
Leng, B
Pellegrin, JL
Citation: P. Blanco et al., Unusual manifestations of type II cryoglobulinaemia associated with Waldenstrom's macroglobulinaemia, J CLIN PATH, 53(11), 2000, pp. 882-884
Authors:
Thiessard, F
Morlat, P
Marimoutou, C
Labouyrie, E
Ragnaud, JM
Pellegrin, JL
Dupon, M
Dabis, F
Citation: F. Thiessard et al., Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus - Aquitaine Cohort, France, 1986-1997, CANCER, 88(7), 2000, pp. 1696-1702
Authors:
Bonnet, F
Dequae-Merchadou, L
Taupin, JL
Sire, S
Dupon, M
Ragnaud, JM
Lacoste, D
Texier-Maugein, J
Romagne, F
Dabis, F
Pellegrin, JL
Moreau, JF
Citation: F. Bonnet et al., Increase in CD3(+) CD4(-) T lymphocytes in patients with AIDS and disseminated Mycobacterium avium-intracellulare complex infection: a prospective study, MICROBES IN, 1(10), 1999, pp. 771-776
Authors:
Viallard, JF
Taupin, JL
Miossec, V
Pellegrin, JL
Leng, B
Moreau, JF
Citation: Jf. Viallard et al., Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupuserythematosus identifies LIF as a potential marker of disease activity, EUR CYTOKIN, 10(1), 1999, pp. 17-23
Authors:
Blanco, P
Viallard, JF
Beylot-Barry, M
Faure, I
Mercie, P
Vergier, B
Pellegrin, JL
Leng, B
Citation: P. Blanco et al., Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with non-Hodgkin's lymphoma, CLIN INF D, 29(3), 1999, pp. 683-684
Authors:
Viallard, JF
Denis, D
Texier-Maugein, J
Parrens, M
Faure, I
Pellegrin, JL
Leng, B
Citation: Jf. Viallard et al., Disseminated infection after bacille Calmette-Guerin instillation for treatment of bladder carcinoma, CLIN INF D, 29(2), 1999, pp. 451-452